Cargando…

Efficacy and Safety of Glimepiride With or Without Linagliptin Treatment in Patients With HNF1A Diabetes (Maturity-Onset Diabetes of the Young Type 3): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial (GLIMLINA)

OBJECTIVE: Sulfonylureas are first-line treatment of hepatocyte nuclear factor 1-α (HNF1A) diabetes (maturity-onset diabetes of the young type 3), but many patients do not achieve optimal glycemic control without episodes of hypoglycemia. We investigated the combination of the sulfonylurea glimepiri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christensen, Alexander S., Hædersdal, Sofie, Støy, Julie, Storgaard, Heidi, Kampmann, Ulla, Forman, Julie L., Seghieri, Marta, Holst, Jens J., Hansen, Torben, Knop, Filip K., Vilsbøll, Tina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440905/ https://www.ncbi.nlm.nih.gov/pubmed/32661107 http://dx.doi.org/10.2337/dc20-0408

Ejemplares similares

Glimepiride monotherapy versus combination of glimepiride and linagliptin therapy in patients with HNF1A-diabetes: a protocol for a randomised, double-blinded, placebo-controlled trial
por: Sidelmann Christensen, Alexander, et al.
Publicado: (2018)

GIP and GLP-1 Potentiate Sulfonylurea-Induced Insulin Secretion in Hepatocyte Nuclear Factor 1α Mutation Carriers
por: Christensen, Alexander S., et al.
Publicado: (2020)

The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride
por: Darsalia, Vladimer, et al.
Publicado: (2013)

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA(®))
por: Marx, Nikolaus, et al.
Publicado: (2015)

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014)

CARdiovascular Outcome study of LINAgliptin versus glimepiride in patients with T2D trial
por: Nath, Baishali, et al.
Publicado: (2020)

Self-efficacy and diabetes prevention in overweight South Asians with pre-diabetes
por: Cioffi, Catherine E, et al.
Publicado: (2018)

Transfer in care and diabetes distress in young adults with type 1 diabetes mellitus
por: Sattoe, Jane, et al.
Publicado: (2021)

Psychometric testing of the Norwegian Diabetes Health Profile (DHP-18) in patients with type 1 diabetes
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2018)

Parental diabetes distress is a stronger predictor of child HbA1c than diabetes device use in school-age children with type 1 diabetes
por: Patton, Susana R, et al.
Publicado: (2023)

Diabetes-related shame among people with type 2 diabetes: an internet-based cross-sectional study
por: Inagaki, Satoshi, et al.
Publicado: (2022)

Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial
por: Mori, Katsuhito, et al.
Publicado: (2016)

Knowledge, attitude, and practice toward pre-diabetes among the public, patients with pre-diabetes and healthcare professionals: a systematic review
por: Teoh, Kah Woon, et al.
Publicado: (2023)

Diabetes causal attributions among affected and unaffected individuals
por: Rose, Margaret K, et al.
Publicado: (2019)

Influence of depression on racial and ethnic disparities in diabetes control
por: Breland, Jessica Y, et al.
Publicado: (2023)

Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
por: Biessels, Geert Jan, et al.
Publicado: (2021)

Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes—A randomized placebo‐controlled crossover trial
por: Lauritzen, Esben S., et al.
Publicado: (2022)

Patients’ perspectives on social and goal-based comparisons regarding their diabetes health status
por: Martinez, William, et al.
Publicado: (2018)

Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study
por: Cameron, Dawn, et al.
Publicado: (2018)

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus
por: Biessels, Geert Jan, et al.
Publicado: (2018)

Positive reinforcement by general practitioners is associated with greater physical activity in adults with type 2 diabetes
por: Geerling, Ralph, et al.
Publicado: (2019)

Adverse effect of long work hours on incident diabetes in 7065 Ontario workers followed for 12 years
por: Gilbert-Ouimet, Mahée, et al.
Publicado: (2018)

Suboptimal diabetic control and psychological burden after the triple disaster in Japan: the Fukushima Health Management Survey
por: Hirai, Hiroyuki, et al.
Publicado: (2021)

Psychological interventions to improve glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis
por: Winkley, Kirsty, et al.
Publicado: (2020)

Factors associated with adherence to using removable cast walker treatment among patients with diabetes-related foot ulcers
por: Ababneh, Anas, et al.
Publicado: (2022)

Development and validation of the self-management Barriers and Supports Evaluation for working-aged adults with type 1 diabetes mellitus
por: Planalp, Elizabeth M, et al.
Publicado: (2022)

Self-compassion, sleep quality and psychological well-being in type 2 diabetes: a cross-sectional study
por: Gunn, Sarah, et al.
Publicado: (2022)

Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial
por: Muskiet, Marcel H. A., et al.
Publicado: (2021)

Longitudinal associations between family conflict, parent engagement, and metabolic control in children with recent-onset type 1 diabetes
por: Case, Hannah, et al.
Publicado: (2021)

Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
por: Yun, Qingping, et al.
Publicado: (2020)

Exploring support needs of people living with diabetes during the coronavirus COVID-19 pandemic: insights from a UK survey
por: Sauchelli, Sarah, et al.
Publicado: (2021)

‘Never again will I be carefree’: a qualitative study of the impact of hypoglycemia on quality of life among adults with type 1 diabetes
por: Chatwin, Hannah, et al.
Publicado: (2021)

The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition
por: Hædersdal, Sofie, et al.
Publicado: (2020)

Responses to the Strengths and Difficulties Questionnaire predict HbA1c trajectories in children and adolescents with type 1 diabetes: a population-based study
por: Marks, Kevin P, et al.
Publicado: (2023)

The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials
por: Storgaard, Heidi, et al.
Publicado: (2014)

The 12-Item Hypoglycemia Impact Profile (HIP12): psychometric validation of a brief measure of the impact of hypoglycemia on quality of life among adults with type 1 or type 2 diabetes
por: Broadley, Melanie, et al.
Publicado: (2022)

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes
por: Hoimark, Lene, et al.
Publicado: (2012)

Parity and type 2 diabetes mellitus: a study of insulin resistance and β-cell function in women with multiple pregnancies
por: Iversen, Ditte Smed, et al.
Publicado: (2016)

Clinical utility and tolerability of linagliptin in diabetic patients
por: Maxwell, Lauralee Gordon, et al.
Publicado: (2013)

Near‐normalization of glycaemic control with glucagon‐like peptide‐1 receptor agonist treatment combined with exercise in patients with type 2 diabetes
por: Mensberg, P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5itgv9ppqikpk6eroq0st9aa47